Treventis Corporation
UEI: PYM6AMMZKBC1
• CAGE: 54ZT1
Overview
Awardee Type
Parent
Federal Capability Statement
Structure-based drug design of molecules impacting on misfolded proteins
Keywords
Drug discovery, neuroscience, CNS, drug design, drug development, pharmaceutical, protein misfolding, Alzheimer's, Parkinson's, amyotrophic lateral sclerosis, cancer, oncology
Website
Headquarters
Bernville, PA
United States
United States
Most Recent Award
June 1, 2023
Calculating
Federal grant recipient
TREVENTIS CORPORATION
dba TREVENTIS CORP
(UEI PYM6AMMZKBC1, CAGE 54ZT1)
is headquartered in Bernville PA.
Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The corporation
was founded in March 2008 and
federally registered in
July 2008.
Federal Award Analysis
Treventis Corporation federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
TREVENTIS CORPORATION
DBA
TREVENTIS CORP
Division Name
N/A
UEI
PYM6AMMZKBC1
CAGE Code
54ZT1
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
March 1, 2008
Initial Registration
July 16, 2008
Last Registration
Sept. 9, 2024
Registration Activation
Sept. 9, 2024
Registration Expiration
Sept. 5, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Reported PSC
Accepts Credit Cards
No